Pharmaceuticals
6 countries across Terumo Asia Pacific officially recognized as Best Workplaces™ Certified by Great Place To Work®
SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Terumo is proud to announce that 6
countries across Terumo Asia Pacific have officially been recognized as Best
Workplaces™ Certified by Great Place To Work®.
MALAYSIA HEALTHCARE DEEPENS BANGLADESH PRESENCE AS MEDICAL TOURISM DEMAND GROWS
CHATTOGRAM, Bangladesh, Sept. 21, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) deepened its engagement in Bangladesh through Malaysia Healthcare Week in Bangladesh, held from 16 to 21 September, bringing Malaysian hospitals and healthcare stakeholders together across Dhaka and C...
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
* Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry's most extensive therap...
New Option To Support Cervical Health In Women With HPV In Singapore
Colpofix®, a vaginal spray gel medical device, supports the regression of HPV-related cervical lesions SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infection, with DKSH's launch of Colpo...
Antengene Announces First Patient Dosed in Pivotal Phase III CLINCH-3 Study of ATG-022
SHANGHAI and HONG KONG, Sept. 21, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...
S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an invitation-only symposium connecting top academic resea...
BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem
SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global:
Jiahui Health Highlights China's Growing Role in Global Medical Tourism at WTO Public Forum 2026
GENEVA, Sept. 18, 2026 /PRNewswire/ -- China is seeing growing momentum in inbound medical tourism, driven by expanding access to innovative therapies, visa facilitation and the development of internationally oriented healthcare services, Dr. John K. Hsiang, Chairman of Jiahui Health Executive Co...
2026 Tang Prize Award Ceremony Honors Six Laureates
Outstanding Achievements for Global Well-Being and Our Shared Future TAIPEI, Sept. 18, 2026 /PRNewswire/ -- The 2026 Tang Prize Award Ceremony brought together all six laureates in Taipei on September 18, with five receiving their awards in person and Biopharmaceutical Science laureate Dr. Steve...
A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
PARIS, Sept. 18, 2026 /PRNewswire/ --
ADVANCION RELEASES 2025 SUSTAINABILITY REPORT: "SAFE BY CHOICE. SUSTAINABLE BY DESIGN."
Advancion's fifth annual report highlights the Company's progress in safety, sustainable innovation and responsible operations BUFFALO GROVE, Ill., Sept. 17, 2026 /PRNewswire/ -- Advancion Corporation ("Advancion" or the "Company"), a global leader in life sciences buffers and proprietary specia...
New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline
ALCOR Scientific's iSED® analyzers reshape lab logistics and improve patient care for one of medicine's most widely used tests * Seven times longer stability, independently validated. ESR samples on ALCOR Scientific's iSED analyzer remained accurate for up to 28 hours at room temperature and 4...
There's No One-Size-Fits-All for Treating Older Adults with Cancer, According to New NCCN Patient Resource
New guideline for patients and caregivers explains the importance of assessments to tailor cancer care to every person, regardless of age. PLYMOUTH MEETING, Pa., Sept. 17, 2026 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—is publ...
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1
medicines and other world-changing advances
LONDON, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc
Tianjin University Leads World's 1st ISO Standard for Single-Herb TCM Formula Granules
TIANJIN, China, Sept. 16, 2026 /PRNewswire/ -- The International Organization for Standardization (ISO) has published ISO 21756:2026, the world's first international standard for single-herb Traditional Chinese Medicine (TCM) formula granules. Titled Traditional Chinese Medicine —Salvia miltiorrh...
OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody
* Cesalatamig is Currently Being Evaluated in Phase 1/2 Studies in the United
States (NCT06635785
Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in Japan for the prevention of migraine attacks
* Approval granted by Japan's Ministry of Health, Labour and Welfare (MHLW) * Eptinezumab is the only intravenous (IV) CGRP-targeted preventive treatment approved for the prevention of migraine attacks in adults and launched in over 30 countries worldwide * Authorization supported by the Pha...
Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease Patients
* The fifteen-month dataset represents the final analysis from the Phase 1/2 study * At the Month 15 primary timepoint, SKY-0515-treated patients showed a +1.59-point difference in Composite Unified Huntington's Disease Rating Scale (cUHDRS) change from baseline versus overlap-weighted extern...
CordenPharma Appoints Dr. Jean-Luc Herbeaux as Chief Executive Officer to Lead Next Phase of Growth
* Dr. Jean-Luc Herbeaux appointed Chief Executive Officer of CordenPharma, effective 1 October 2026 * Dr. Michael Quirmbach to transition from President & CEO to Board Member and Senior Advisor, remaining actively involved with CordenPharma * Planned leadership transition builds on 12 ye...
5th Hong Kong International Biotechnology Conference and Exhibition (BIOHK2026) Officially Opens
HONG KONG, Sept. 11, 2026 /PRNewswire/ -- Hong Kong International Biotechnology Conference and Exhibition (BIOHK2026) officially opened on September 9, 2026, at the Hong Kong Convention and Exhibition Centre. Marking a key 5-year milestone, this flagship life sciences event connects Hong Kong, Ma...
Week's Top Stories
Most Reposted
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
[Picked up by 294 media titles]
2026-10-22 22:35SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 276 media titles]
2026-10-21 15:00DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 270 media titles]
2026-10-22 11:55Carro Establishes Inaugural SGD450 Million Asset-Backed Securitisation Warehouse Facility
[Picked up by 267 media titles]
2026-10-22 11:00